Recent Advances in the Synthesis of 2-Substituted Oxetanes by Davis, O & Bull, JA
1 SYNLETT: SYNPACTS (INVITED ARTICLE)  
Template for SYNLETT and SYNTHESIS © Thieme  Stuttgart · New York 2015-05-23 page 1 of 6 
Abstract: Recent interest in oxetanes in medicinal chemistry 
and as synthetic intermediates has led to the development of a 
number of methods for the synthesis of more functionalized 
and highly substituted oxetane derivatives. Here we review 
cyclization approaches for the preparation of 2-substituted 
oxetanes. Methods involving C–O bond formation, as well as 
recently developed C–C bond forming cyclization strategies are 
highlighted. 
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The synthesis of oxetanes, 4-membered cyclic ethers, 
poses a challenge due to the combination of inherent 
ring strain and poor kinetics of cyclization. Recent 
interest in the properties of these small rings has 
prompted the development of a variety of new 
methods for their synthesis. Oxetanes find extensive 
use in polymer chemistry,1 and are increasingly used 
as synthetic intermediates in ring opening or 
rearrangement reactions.2,3 Moreover, the 
incorporation of oxetanes has been shown to improve 
physicochemical properties of drug-like molecules.4 
Carreira has extensively investigated 3,3-disubstituted 
oxetanes as polar replacements for carbonyl and gem-
dimethyl groups.5 Synthetic and stability studies of 
these substrates prompted a dramatic increase in the 
use of 3- and 3,3-disubstituted oxetanes in medicinal 
chemistry programs. Although the oxetane motif is 
embedded in a number of biologically important 
natural products,6 previous studies on oxetane 
derivatives in drug discovery have been limited.7 
Oxetanes still continue to provide unexplored 
chemical space to be investigated in this context. 
While achiral 3-substituted oxetanes have become 
more accessible,4,5,8 synthetic limitations remain for 2-
substituted derivatives, which introduce a chiral 
center, and more highly substituted examples. These 
more complex structures offer additional vectors to be 
exploited in medicinal chemistry, and more varied 
substitution for use as synthetic intermediates. This 
article will summarise some recent synthetic advances 
towards the formation of 2-substituted oxetanes, and 
highlight our recent contributions. Selected recent 
examples of the following reaction classes are 
presented (Scheme 1): 
a) C–O bond forming cyclization 
b) ring expansion of epoxides 
c) Paternò-Büchi reaction: [2+2] photochemical 
cycloaddition 
d) C–C bond forming cyclization, highlighting 
recent work from our group. 
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Scheme 1 Synthetic approaches to 2-substituted oxetanes. 
The most recent applications of intramolecular 
Williamson etherification have occurred in the 
synthesis of spirocyclic oxetanes.9 For example,  
2’-spirooxetane ribonucleoside derivatives have been 
developed to target the hepatitis C virus.10 In addition, 
Carreira has developed syntheses of various 
spirocyclic oxetanes as novel chemical modules.11 A 
recent example was the preparation of an interesting 
oxetane 2-carboxylate that was spiro-linked with an 
azetidine (Scheme 2a).12 Addition of furyllithium to 
an azetidine aldehyde afforded the cyclization 
precursor. Cyclization to the spiro-oxetane occurred 
successfully under mild basic conditions (K2CO3, 
MeOH). This choice of conditions for cyclization was 
crucial for this substrate as the use of KOtBu 
promoted a Grob fragmentation to give a 3-exo-
methylene azetidine. The furan substituent was then 
oxidized to afford the desired carboxylic acid.  
An attractive route to suitable precursors for 
cyclization to oxetanes is the opening of epoxides 
with an ylide, which is followed directly by ring 
closure.13 In 2009 Shibasaki reported a catalytic 
enantioselective one-pot synthesis of oxetanes from 
prochiral ketones via the epoxide (Scheme 2b).14 This 
involved the formation of the chiral epoxide in 
excellent ee using a chiral heterobimetallic complex 
and one equivalent of the Corey-Chaykovsky reagent. 
A second equivalent of the sulfoxonium ylide effected 
the ring expansion to the oxetane. The enantiopurity 
was further amplified in the second step due to a 
partial kinetic resolution of the intermediates. 2,2-
Disubstituted oxetanes were obtained from methyl 
ketones with 99% ee and in excellent yield. 
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Scheme 2 a) Carreira’s synthesis of spiro-linked oxetane-azetidine by Williamson etherification. b) Shibasaki’s enantioselective synthesis of 
oxetanes from ketones.
Another classical approach to oxetane synthesis is the 
Paternò-Büchi photochemical [2+2] cycloaddition,15 
which forms both C–O and C–C bonds via diradical 
species. In 2009, based on extensive previous work, 
Bach reported a general procedure for the synthesis of 
3-(silyloxy)oxetanes and protected 3-aminooxetanes. 
This was achieved by irradiating aromatic aldehydes 
and silyl enols or N-acyl enamines, respectively, with 
ultraviolet light (Scheme 3a).16 Good yields were 
obtained and reactions occurred with high 
diastereoselectivity, with a cis-configuration between 
the aromatic and silyl ether/amine being favoured.  
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Scheme 3 Paternò-Büchi photochemical [2+2] cycloadditions. 
In 2011, Griesbeck reported that certain methyl-
substituted isoxazoles were capable of undergoing the 
Paternò-Büchi reaction with a variety of aromatic 
aldehydes (Scheme 3b).17 Moderate yields of the 
fused bicycles were obtained and reactions occurred 
with high regioselectivity and exo-diastereoselectivity.  
The Bull group recently reported the synthesis of 2-
sulfonyl oxetanes, designed as desirable fragments for 
fragment-based drug discovery.18 Traditional 
cyclization approaches to synthesize these compounds 
were unsuitable due to the instability of the required 
intermediates. Therefore, a C–C bond forming 
cyclization was developed, which had not been 
previously investigated for oxetane synthesis (Scheme 
4a). An appropriate cyclization precursor was 
prepared in 3-steps from readily available 
chloromethyl aryl-sulfides. Deprotonation to generate 
the sulfone stabilized carbanion effected smooth 
cyclization. Excellent yields of the desired 2-sulfonyl 
oxetanes were obtained using LiHMDS (1.1 equiv) in 
THF at 0 °C on gram scales.  
Further substituents were introduced on the 2-sulfonyl 
oxetanes through deprotonation and reaction with 
electrophiles (Scheme 4b).18,19 Two different sets of 
conditions were developed; LiHMDS or n-BuLi at 
low temperature depending on the compatibility with 
the electrophiles, providing 2,2-disubstituted oxetanes 
in excellent yields. Suzuki cross-coupling of the 
chlorophenyl containing oxetane (in Scheme 4) was 
also achieved to afford bi-aryl derivatives in good 
yields (not shown). 
We proposed that this strategy may provide more 
facile access to more functionalized and highly 
substituted oxetane derivatives, and overcome some 
of the limitations of C–O cyclization approaches. To 
enable this, we exploited an O–H insertion to expedite 
the synthesis.20 Targeting 2,2-oxetane dicarboxylate, 
the cyclization precursor could be prepared in 1 step 
from diethyl diazomalonate and 2-bromoethanol using 
catalytic rhodium acetate dimer (Scheme 5). The O–H 
insertion occurred selectively in high yield with no 
indication of competing epoxidation. Intramolecular 
cyclization with the malonate anion displacing the 
bromide was effective using NaH (1.2 equiv) in DMF 
at 0 °C in 1 h, providing a rapid 2-step route to 
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oxetane derivatives. Bromides were shown to afford 
improved yields in the cyclization versus iodide and 
tosylate leaving groups. 
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Scheme 4 Synthesis and functionalization of 2-sulfonyl oxetanes.
HO
Br
Rh2(OAc)4
(0.5 mol%) O
Br
EtO2C
EtO2C
90%
EtO2C
EtO2C
N2
NaH (1.2 equiv) O
EtO2C
EtO2C
71%
PhH, 80 ºC
90 min
DMF, 0 ºC
1 h
 
Scheme 5 Synthesis of 2,2-diethyl oxetane dicarboxylate by O–H 
insertion/C–C bond forming cyclization. 
The introduction of substituents onto 2-bromoethanol 
was then examined to form chiral oxetanes. Both aryl 
and alkyl substituted β-bromohydrins were readily 
prepared on route to 2,2,4-trisubsituted oxetanes 
(Scheme 6). The O–H insertion was generally 
successful across the range of substrates, with the 
same conditions employed as for the unsubstituted 
example. The cyclization required a longer reaction 
time (16 h) and higher temperature (25 °C) to achieve 
complete conversion and excellent yields. A wide 
range of substituted aryl groups was well tolerated 
(Scheme 6a), including halogenated, electron-rich and 
electron-poor aromatic substituents in similarly high 
yields. The sequence was performed with the 
enantioenriched phenyl-substituted β-bromohydrin. 
As expected, the ee was perfectly retained through 
both the O–H insertion and cyclization steps, 
accessing the enantioenriched oxetane. As such, 
enantioenriched oxetanes are readily available from 
enantioenriched β-bromohydrins.21 The synthetic 
sequence was also high yielding on a gram scale.  
Alkyl substituents were well tolerated through the 
reaction sequence (Scheme 6b). Several functional 
groups were introduced at the 4-position of the 
oxetane, including ethers, a bromomethyl group, and a 
trifluoromethyl group. Chlorides were also viable 
leaving groups for oxetane synthesis (Scheme 6c). 
From the corresponding chlorohydrins, a 
chloromethyl group and also a silyl protected alcohol 
were introduced at the 4-position, with high yields 
over both steps. 
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Scheme 6 Synthesis of 2,2,4-trisubstituted oxetane derivatives (selected examples).
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Scheme 7 Synthesis of tetrasubstituted oxetanes by O–H insertion/C–C bond forming cyclization
This method was expanded further to the synthesis of 
sterically congested tetrasubstituted oxetane 
derivatives, demonstrating that the cyclization was not 
limited to primary halides. Using cyclic alkenes, to 
access fused oxetane derivatives, anti-substituted 
bromohydrins were generated on treatment with NBS/ 
H2O (Scheme 7). From 2,6-dihydrofuran, cyclohexene 
and cyclopentene the corresponding fused oxetanes 
were generated with high yields across each of the 3-
step sequences. From trans-stilbene, 2,2-diester-3,4-
diphenyl oxetane was prepared as a single anti-
diastereoisomer. Similarly, the corresponding 2,2,4,4-
substituted oxetane was prepared from α-
methylstyrene.  
The diester products were further elaborated to 
generate oxetane containing fragments and building 
blocks of interest in drug discovery (Scheme 8). The 
diester functionality could be reduced to the diol using 
in situ generated LiBH4 (Scheme 8a). This was 
converted to the mono-tosylate and subsequent 
Williamson cyclization afforded an unusual angular 
bis-oxetane spirocycle. The diester successfully 
underwent Krapcho decarboxylation using LiCl, 
affording the readily separable cis- and trans-2,4-
substituted oxetanes (Scheme 8b). Mono-hydrolysis of 
the diester moiety with NaOH afforded the mono-
carboxylate sodium salt which was directly coupled 
with morpholine using HATU (Scheme 8c). Finally, 
the bromomethyl oxetane was reacted with sodium 
azide to form the primary alkyl azide, which 
underwent a Huisgen azide cycloaddition with phenyl 
acetylene using copper sulfate (Scheme 8d).  
In summary, several methods have been developed for 
the preparation of highly substituted oxetane 
derivatives. In addition to developments in more 
traditional C–O bond forming strategies, C–C bond 
forming cyclization has emerged as a powerful 
approach to oxetane synthesis. Highly substituted 
oxetanes containing suitable functionality for further 
derivatization, as well as enantioenriched examples, 
have been prepared by this approach. Given the 
interest in oxetane structures and properties, it is 
likely further methods will be developed for the 
efficient preparation of oxetanes. This will further 
enable the full study and exploitation of oxetanes as 
motifs for synthesis and medicinal chemistry.  
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Scheme 8 Selected examples of derivatization of diester oxetanes.  
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